Loading organizations...
§ Private Profile · Chicago, IL, USA
Biotech company developing mini-chromosome technology for agriculture, accelerating crop improvement and enhancing plant traits.
Chromatin Inc. is a Chicago, Illinois-based agricultural biotechnology company that develops mini-chromosome technology to accelerate crop improvement through the rapid delivery and stacking of multiple genes into plants. The organization focuses on enhancing the nutritional value, food safety, disease resistance, drought tolerance, and overall yield of agricultural products, with a specific emphasis on optimizing sorghum varieties. These improved seed varieties are designed to support farmers across diverse geographic regions, including Africa, Asia, North America, and South America. Operating facilities in both Chicago and Urbana, the enterprise grew its workforce to more than 30 employees to support its ongoing research and development initiatives. The company's executive leadership and board have included industry figures such as former President Mich Hein and Chairman Roger Wyse. Chromatin was founded in 2000 by Daphne Preuss and Greg Copenhaver.
Chromatin has raised $70.5M across 4 funding rounds.
Chromatin has raised $70.5M in total across 4 funding rounds.
Chromatin has raised $70.5M across 4 funding rounds. Most recently, it raised $12.0M Series F in January 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 20, 2015 | $12M Series F | Illinois Ventures, Wood Creek Capital Management | — | Announced |
| Jul 9, 2014 | $12.5M Debt Financing | The PrivateBank | — | Announced |
| Jan 9, 2014 | $36M Series E | BOB Saul | Adventures IV, BP Alternative Energy, Equity, GE Capital, Illinois Ventures, State OF Wisconsin Investment Board | Announced |
| Oct 25, 2011 | $10M Series D | — | Justin Adams OBE, Illinois Ventures, Malaysian Life Sciences Capital Fund, Quantitative Investment Holdings, Unilever Ventures | Announced |
Chromatin has raised $70.5M in total across 4 funding rounds.
Chromatin's investors include Illinois Ventures, Wood Creek Capital Management, The PrivateBank, Bob Saul, Adventures IV, BP Alternative Energy, Equity, GE Capital, State of Wisconsin Investment Board, Justin Adams OBE, Malaysian Life Sciences Capital Fund, Quantitative Investment Holdings.